192 related articles for article (PubMed ID: 15713234)
21. Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation.
Punj V; Matta H; Schamus S; Yang T; Chang Y; Chaudhary PM
Blood; 2009 May; 113(22):5660-8. PubMed ID: 19324905
[TBL] [Abstract][Full Text] [Related]
22. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
Kelly GD; Morris CB; Offermann MK
Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088
[TBL] [Abstract][Full Text] [Related]
23. The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation.
Sun Q; Zachariah S; Chaudhary PM
J Biol Chem; 2003 Dec; 278(52):52437-45. PubMed ID: 14563855
[TBL] [Abstract][Full Text] [Related]
24. Association of p65 and C/EBPbeta with HIV-1 LTR modulates transcription of the viral promoter.
Mukerjee R; Sawaya BE; Khalili K; Amini S
J Cell Biochem; 2007 Apr; 100(5):1210-6. PubMed ID: 17031851
[TBL] [Abstract][Full Text] [Related]
25. Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.
Wires ES; Alvarez D; Dobrowolski C; Wang Y; Morales M; Karn J; Harvey BK
J Neurovirol; 2012 Oct; 18(5):400-10. PubMed ID: 22618514
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways.
An J; Sun Y; Sun R; Rettig MB
Oncogene; 2003 May; 22(22):3371-85. PubMed ID: 12776188
[TBL] [Abstract][Full Text] [Related]
27. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
[TBL] [Abstract][Full Text] [Related]
28. Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice.
Chugh P; Matta H; Schamus S; Zachariah S; Kumar A; Richardson JA; Smith AL; Chaudhary PM
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12885-90. PubMed ID: 16120683
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter.
El Kharroubi A; Piras G; Zensen R; Martin MA
Mol Cell Biol; 1998 May; 18(5):2535-44. PubMed ID: 9566873
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
Harhaj E; Blaney J; Millhouse S; Sun SC
Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
[TBL] [Abstract][Full Text] [Related]
31. Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation?
Samaniego F; Pati S; Karp JE; Prakash O; Bose D
J Natl Cancer Inst Monogr; 2001; (28):15-23. PubMed ID: 11158202
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma-associated herpesvirus ORF45 mediates transcriptional activation of the HIV-1 long terminal repeat via RSK2.
Karijolich J; Zhao Y; Peterson B; Zhou Q; Glaunsinger B
J Virol; 2014 Jun; 88(12):7024-35. PubMed ID: 24719417
[TBL] [Abstract][Full Text] [Related]
33. Interplay between NFBP and NF-kappaB modulates tat activation of the LTR.
Sweet T; Sawaya BE; Khalili K; Amini S
J Cell Physiol; 2005 Aug; 204(2):375-80. PubMed ID: 15887232
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
35. Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds.
Barbeau B; Bernier R; Dumais N; Briand G; Olivier M; Faure R; Posner BI; Tremblay M
J Biol Chem; 1997 May; 272(20):12968-77. PubMed ID: 9148903
[TBL] [Abstract][Full Text] [Related]
36. Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice.
Ahmad A; Groshong JS; Matta H; Schamus S; Punj V; Robinson LJ; Gill PS; Chaudhary PM
Cancer Biol Ther; 2010 Nov; 10(10):1033-40. PubMed ID: 20818173
[TBL] [Abstract][Full Text] [Related]
37. An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.
Mallardo M; Dragonetti E; Baldassarre F; Ambrosino C; Scala G; Quinto I
J Biol Chem; 1996 Aug; 271(34):20820-7. PubMed ID: 8702837
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide inhibits HIV tat-induced NF-kappaB activation.
Chen F; Lu Y; Castranova V; Rojanasakul Y; Miyahara K; Shizuta Y; Vallyathan V; Shi X; Demers LM
Am J Pathol; 1999 Jul; 155(1):275-84. PubMed ID: 10393859
[TBL] [Abstract][Full Text] [Related]
39. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
Popik W; Pitha PM
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9573-7. PubMed ID: 1719535
[TBL] [Abstract][Full Text] [Related]
40. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]